4G Clinical Launches Direct-to-Patient Platform

April 9, 2020

Applied Clinical Trials

4G Clinical has announced the launch of a Direct-to-Patient (DtP) clinical trial platform, offering sponsors the flexibility to ship drug from the sites to the patient's home. In the midst of the COVID-19 pandemic, clinical trial models are shifting towards DtP to address patient safety & access to trial sites, site capacity challenges, and supply chain disruption.  

For more information, click here.

Related Content:

News